Dr Hannah L Craig
Driving Scientific Innovation:
Strategic Architect of Next-Generation Drug Discovery Platforms
As former Head of Transgenic Science and Services at Sanofi and a key leader at Kymab, I bring deep expertise in:
Strategic development of novel drug discovery platforms
Design and implementation of genome engineering programs
Management of global research operations
Cross-functional team leadership and integration
Complex stakeholder and partnership management
My experience spans the full spectrum of biotech innovation—from startup environments to global pharmaceutical operations—enabling me to offer unique insights into platform development, team integration, and strategic research planning. I've successfully led multiple transformative projects, including the development of revolutionary antibody discovery platforms.
Some specifics:
Lead a global team encompassing genome engineering, tissue culture, animal sciences and outsourcing of a range activities related to in vivo tool provision.
Delivered multiple innovative, and transformative, engineered rodent drug discovery platforms, from conception to roll-out and application.
Pioneered the use of novel platforms to accelerate effective discovery of alternative biologic formats, such as bispecific and single domain, in vivo.
Drove modernisation of genome engineering activities via adoption of emerging techniques.
Key scientific point of contact for several external partnering relationships.
Member of UK site senior leadership team.
Steered a team through both an acquisition/integration and a site closure, with a focus on with empathy and integrity.